BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Steffen RE, Pinto M, Kritski A, Trajman A. Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV. Sci Rep 2020;10:21823. [PMID: 33311520 DOI: 10.1038/s41598-020-78737-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Gong W, Liang Y, Wang J, Liu Y, Xue Y, Mi J, Li P, Wang X, Wang L, Wu X. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Mycobacterium tuberculosis and Evaluation of Their Potential in the Diagnosis of Tuberculosis in a Mouse Model and in Humans. Microbiol Spectr 2022;:e0143822. [PMID: 35938824 DOI: 10.1128/spectrum.01438-22] [Reference Citation Analysis]
2 Santiago PHO, Bessa MAS, Menezes RP, Martins CHG, Gatto CC. Zn(II) complexes with a new isoniazid ligand: synthesis, structural characterization and antimycobacterial activity. Journal of Coordination Chemistry. [DOI: 10.1080/00958972.2022.2052283] [Reference Citation Analysis]
3 Auguste PE, Mistry H, McCarthy ND, Sutcliffe PA, Clarke AE. Cost-effectiveness of testing for latent tuberculosis infection in people with HIV. AIDS 2022;36:1-9. [PMID: 34873091 DOI: 10.1097/QAD.0000000000003060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021;12:745592. [PMID: 34745048 DOI: 10.3389/fmicb.2021.745592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]